- ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
- Cancer (Oncology)
- Hospital Affiliations
- Mount Sinai Beth Israel
- The Mount Sinai Hospital
- Aplastic Anemia
- Blood Transfusion
- Bone Marrow Biopsy
- Myelodysplastic Syndromes
- Primary Polycythemia
MD, University of Illinois
Residency, Internal Medicine
University of Michigan Hospitals
Fellowship, Hematology & Oncolog
Mount Sinai Hospital
A Phase 3 Open-Label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation
The purpose of this study is to evaluate the safety and effectiveness of an investigational drug called ASP2215 in treatment for AML patients with mutations in FLT3 gene identified by an investigational FLT3 test using your blood or bone marrow to see if you have a mutations of t...
Phase I/II, Multi-center, Dose-escalating Study of the Tolerability, Pharmacokinetics, and Clinical Activity of the Combined Administration of Oral Rigosertib with Azacitidine in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia
The purpose of this study is to evaluate the tolerability and effectiveness of an oral formulation of Rigosertib combined with Azacitidine (Vidaza®) in treating your condition and to find the best
Version A, B
Page 2 of 14 IRB approved from 23Jul2013...
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Navada during 2017 and/or 2018. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Onconova Therapeutics, Inc.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Merck & Co., Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.